
### [Orphanet:593](http://www.orpha.net/ORDO/Orphanet_593)
**Label:** Myofibrillar myopathy

**Subclasses:** [Orphanet:98911](http://www.orpha.net/ORDO/Orphanet_98911) (Distal myotilinopathy), [Orphanet:268129](http://www.orpha.net/ORDO/Orphanet_268129) (Spheroid body myopathy), [Orphanet:171445](http://www.orpha.net/ORDO/Orphanet_171445) (Muscle filaminopathy), [Orphanet:98909](http://www.orpha.net/ORDO/Orphanet_98909) (Desminopathy), [Orphanet:199340](http://www.orpha.net/ORDO/Orphanet_199340) (Muscular dystrophy, Selcen type), [Orphanet:98912](http://www.orpha.net/ORDO/Orphanet_98912) (Late-onset distal myopathy, Markesbery-Griggs type), 

**Corr. equiv. classes:** [Orphanet:98909](http://www.orpha.net/ORDO/Orphanet_98909), [Orphanet:199340](http://www.orpha.net/ORDO/Orphanet_199340), [OMIM:609524](http://purl.obolibrary.org/obo/OMIM_609524), [OMIM:612954](http://purl.obolibrary.org/obo/OMIM_612954), [Orphanet:171445](http://www.orpha.net/ORDO/Orphanet_171445), [Orphanet:268129](http://www.orpha.net/ORDO/Orphanet_268129), [Orphanet:98911](http://www.orpha.net/ORDO/Orphanet_98911), [Orphanet:98912](http://www.orpha.net/ORDO/Orphanet_98912), [OMIM:609452](http://purl.obolibrary.org/obo/OMIM_609452), [OMIM:609200](http://purl.obolibrary.org/obo/OMIM_609200), [OMIM:601419](http://purl.obolibrary.org/obo/OMIM_601419), [OMIM:182920](http://purl.obolibrary.org/obo/OMIM_182920), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) 66.67%
- [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 66.67%
- [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.67%
- [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.67%
- [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.67%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 66.67%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 66.67%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 66.67%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) 66.67%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) 66.67%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 66.67%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0003715](http://purl.obolibrary.org/obo/HP_0003715) (Myofibrillar myopathy) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.67%


